| 69539-021-99 |
69539-021 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20191120 |
N/A |
ANDA |
ANDA209878 |
MSN LABORATORIES PRIVATE LIMITED |
DEFERASIROX |
125 mg/1 |
1000 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-021-99) |
| 69539-022-06 |
69539-022 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20200212 |
N/A |
ANDA |
ANDA209878 |
MSN LABORATORIES PRIVATE LIMITED |
DEFERASIROX |
250 mg/1 |
10 BLISTER PACK in 1 CARTON (69539-022-06) / 10 TABLET, FOR SUSPENSION in 1 BLISTER PACK (69539-022-11) |
| 69539-022-30 |
69539-022 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20191120 |
N/A |
ANDA |
ANDA209878 |
MSN LABORATORIES PRIVATE LIMITED |
DEFERASIROX |
250 mg/1 |
30 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-022-30) |
| 69539-022-90 |
69539-022 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20191120 |
N/A |
ANDA |
ANDA209878 |
MSN LABORATORIES PRIVATE LIMITED |
DEFERASIROX |
250 mg/1 |
90 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-022-90) |
| 69539-022-99 |
69539-022 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20191120 |
N/A |
ANDA |
ANDA209878 |
MSN LABORATORIES PRIVATE LIMITED |
DEFERASIROX |
250 mg/1 |
1000 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-022-99) |
| 69539-023-05 |
69539-023 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20191120 |
N/A |
ANDA |
ANDA209878 |
MSN LABORATORIES PRIVATE LIMITED |
DEFERASIROX |
500 mg/1 |
500 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-023-05) |
| 69539-023-06 |
69539-023 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20200212 |
N/A |
ANDA |
ANDA209878 |
MSN LABORATORIES PRIVATE LIMITED |
DEFERASIROX |
500 mg/1 |
10 BLISTER PACK in 1 CARTON (69539-023-06) / 10 TABLET, FOR SUSPENSION in 1 BLISTER PACK (69539-023-11) |
| 69539-021-90 |
69539-021 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20191120 |
N/A |
ANDA |
ANDA209878 |
MSN LABORATORIES PRIVATE LIMITED |
DEFERASIROX |
125 mg/1 |
90 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-021-90) |
| 69539-021-30 |
69539-021 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20191120 |
N/A |
ANDA |
ANDA209878 |
MSN LABORATORIES PRIVATE LIMITED |
DEFERASIROX |
125 mg/1 |
30 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-021-30) |
| 69539-021-06 |
69539-021 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20200212 |
N/A |
ANDA |
ANDA209878 |
MSN LABORATORIES PRIVATE LIMITED |
DEFERASIROX |
125 mg/1 |
10 BLISTER PACK in 1 CARTON (69539-021-06) / 10 TABLET, FOR SUSPENSION in 1 BLISTER PACK (69539-021-11) |
| 69539-023-30 |
69539-023 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20191120 |
N/A |
ANDA |
ANDA209878 |
MSN LABORATORIES PRIVATE LIMITED |
DEFERASIROX |
500 mg/1 |
30 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-023-30) |
| 69539-023-90 |
69539-023 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20191120 |
N/A |
ANDA |
ANDA209878 |
MSN LABORATORIES PRIVATE LIMITED |
DEFERASIROX |
500 mg/1 |
90 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-023-90) |
| 72205-389-05 |
72205-389 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20260129 |
N/A |
ANDA |
ANDA209878 |
Novadoz Pharmaceuticals LLC |
DEFERASIROX |
125 mg/1 |
10 BLISTER PACK in 1 CARTON (72205-389-05) / 10 TABLET, FOR SUSPENSION in 1 BLISTER PACK |
| 72205-390-01 |
72205-390 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20260129 |
N/A |
ANDA |
ANDA209878 |
Novadoz Pharmaceuticals LLC |
DEFERASIROX |
250 mg/1 |
30 TABLET, FOR SUSPENSION in 1 BOTTLE (72205-390-01) |
| 72205-390-02 |
72205-390 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20260129 |
N/A |
ANDA |
ANDA209878 |
Novadoz Pharmaceuticals LLC |
DEFERASIROX |
250 mg/1 |
90 TABLET, FOR SUSPENSION in 1 BOTTLE (72205-390-02) |
| 72205-390-03 |
72205-390 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20260129 |
N/A |
ANDA |
ANDA209878 |
Novadoz Pharmaceuticals LLC |
DEFERASIROX |
250 mg/1 |
1000 TABLET, FOR SUSPENSION in 1 BOTTLE (72205-390-03) |
| 72205-390-05 |
72205-390 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20260129 |
N/A |
ANDA |
ANDA209878 |
Novadoz Pharmaceuticals LLC |
DEFERASIROX |
250 mg/1 |
10 BLISTER PACK in 1 CARTON (72205-390-05) / 10 TABLET, FOR SUSPENSION in 1 BLISTER PACK |
| 72205-391-01 |
72205-391 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20260129 |
N/A |
ANDA |
ANDA209878 |
Novadoz Pharmaceuticals LLC |
DEFERASIROX |
500 mg/1 |
30 TABLET, FOR SUSPENSION in 1 BOTTLE (72205-391-01) |
| 72205-391-02 |
72205-391 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20260129 |
N/A |
ANDA |
ANDA209878 |
Novadoz Pharmaceuticals LLC |
DEFERASIROX |
500 mg/1 |
90 TABLET, FOR SUSPENSION in 1 BOTTLE (72205-391-02) |
| 72205-391-03 |
72205-391 |
HUMAN PRESCRIPTION DRUG |
Deferasirox |
Deferasirox |
TABLET, FOR SUSPENSION |
ORAL |
20260129 |
N/A |
ANDA |
ANDA209878 |
Novadoz Pharmaceuticals LLC |
DEFERASIROX |
500 mg/1 |
500 TABLET, FOR SUSPENSION in 1 BOTTLE (72205-391-03) |